securities class action

$SLNO investors urged to join class action over undisclosed DCCR safety concerns; May 5, 2026 deadline.

Law firm investigates Zynex securities fraud claims; investors face April 2026 deadline for federal class action lawsuit over alleged revenue inflation and Tricare payment fraud.

TruBridge disclosed material accounting errors in 2023-2025 financials, triggering a 10.5% stock decline and spurring shareholder litigation.

Boston Scientific faces class action over false electrophysiology segment statements. Investors from July 2025–February 2026 may recover damages; lead plaintiff deadline May 4, 2026.

$EOSE faces class action lawsuit over alleged false production capacity and performance claims. Lead plaintiff deadline: May 5, 2026.

Rosen Law Firm seeks lead plaintiffs in securities lawsuit against Aquestive Therapeutics over alleged false statements regarding Anaphylm drug application.

Aldeyra Therapeutics stock plunged 71% after FDA rejected its reproxalap dry eye drug, prompting a securities investigation by Rosen Law Firm.

Rosen Law Firm filed a class action lawsuit against Gartner ($IT) alleging false statements about growth targets. Lead plaintiff deadline is May 18, 2026.

Eos Energy Enterprises ($EOSE) faces securities lawsuit after missing revenue guidance by $35-46M, citing production issues. May 5, 2026 deadline for investor claims.

Rosen Law Firm urges MREO investors to act before April 6, 2026 deadline in securities class action alleging misleading clinical trial statements.

Picard Medical faces securities fraud lawsuit alleging false statements, social media manipulation, and insider share dumping scheme during September-October 2025 period.

Rosen Law Firm alerts Ramaco Resources investors of March 31, 2026 deadline to join securities lawsuit alleging false statements about Brook Mine operations.

$APO investors must act before May 1, 2026 deadline in securities lawsuit alleging executives falsely denied Epstein business relationship.

$TCOM faces securities class action over alleged monopolistic practices; investors must act by May 11, 2026 deadline.

Securities lawsuit filed against $NSCL alleging false statements about commercialization partner ENTRA1 Energy's nuclear experience. Lead plaintiff deadline: April 20, 2026.

Rosen Law Firm seeks lead plaintiffs in securities class action against Inovio Pharmaceuticals for alleged misstatements on device defects, regulatory prospects, and product timelines. Lead plaintiff deadline: April 7, 2026.

Richtech Robotics faces securities class action after Microsoft denied partnership, stock crashed 20% following 30% surge on alleged false collaboration announcement.

Rosen Law Firm urges $MNDY investors to join class action lawsuit alleging false revenue guidance. Lead plaintiff deadline set for May 11, 2026.

Rosen Law Firm urges PomDoctor investors to join securities class action by April 7, 2026 deadline alleging false statements, social media fraud, and insider share dumping.

Rosen Law Firm notifies $RARE investors of securities class action alleging materially false statements about setrusumab efficacy in Phase III trials, with April 6, 2026 lead plaintiff deadline.